Recent News

• 06.10.2025 - BioRestorative Welcomes Serial Regenerative Medicine Entrepreneur, Company Builder and Leader, Sandy Lipkins, to BRTX Team
• 06.10.2025 - BioRestorative Welcomes Serial Regenerative Medicine Entrepreneur, Company Builder and Leader, Sandy Lipkins, to BRTX Team
• 06.09.2025 - BioRestorative to Present Major Update on Promising Preliminary Phase 2 BRTX-100 Data at ISSCR 2025
• 06.09.2025 - BioRestorative to Present Major Update on Promising Preliminary Phase 2 BRTX-100 Data at ISSCR 2025
• 05.14.2025 - BioRestorative Therapies Reports First Quarter 2025 Financial Results and Provides Business Update
• 05.14.2025 - BioRestorative Therapies Reports First Quarter 2025 Financial Results and Provides Business Update
• 05.13.2025 - Phase 2 Trial of BRTX-100 in cLDD Continues to Generate Positive Preliminary Blinded Data
• 05.13.2025 - Phase 2 Trial of BRTX-100 in cLDD Continues to Generate Positive Preliminary Blinded Data
• 05.08.2025 - BioRestorative Therapies to Report First Quarter 2025 Financial Results and Host Conference Call on May 14, 2025
• 05.08.2025 - BioRestorative Therapies to Report First Quarter 2025 Financial Results and Host Conference Call on May 14, 2025

Recent Filings

• 05.15.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 05.14.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.14.2025 - EX-99.1 EX-99.1
• 05.14.2025 - 8-K Current report
• 04.21.2025 - 8-K Current report
• 03.28.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]